Loteprednol Etabonate

氯替泼诺

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameLoteprednol Etabonate
Drug Alias Name氯替泼诺碳酸乙酯loteprednolum依碳氯替泼诺依碳酸氯替泼诺Locort +[18] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionCytosolic phospholipase A2 agonistsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorCytosolic phospholipase A2
Therapy Area/IndicationsOcular inflammationPainPain, Postoperative +[24] 
Global Approved IndicationsOcular inflammationRosaceaAcne Vulgaris +[14] 
Approved Indications in ChinaOcular inflammationIritisKeratitis +[8] 
Original Approved Country/TerritoryUnited States
Original Approved Date1998/03/09
Country/TerritoryCanadaUnited StatesSingapore +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBausch & Lomb
China Registration ClassN/A

Develop Information

Active CompaniesBausch & Lomb IncorporatedBausch And Lomb IncAlcon Laboratories Inc
Inactive CompaniesSandozPharmos CorpKala Pharmaceuticals Inc +[4] 
Active IndicationsOcular inflammationPain, PostoperativeInflammation +[14] 
Inactive IndicationsPainPostoperative ComplicationsRosacea +[10] 

Other Information

ATC CodeS01BA14
Related LinksWikipediaDrugBankKEGG